myristamide

tetradecylamide

CAS: 638-58-4 C14 H29 N O MW: 227.39133000

Identification

Namemyristamide
IUPACtetradecanamide
CAS Number638-58-4
EINECS211-343-2
FDA UNIIA269J8QG0O
Molecular FormulaC14 H29 N O
Molecular Weight227.39133000
MDL NumberMFCD00025533
Nikkaji NumberJ43.214H
XlogP34.60 (est)

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Melting Point 104.00 °C. @ 760.00 mm Hg
Soluble in water, 2.864 mg/L @ 25 °C (est)

No sensory data available

Safety Information

Preferred SDSView
Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryinformation only not used for fragrances or flavors
Recommendation for myristamide usage levels up tonot for fragrance use.
Recommendation for myristamide flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

myristic acid amide myristic amide myristyl amide tetradecanamide tetradecyl amide tetradecylamide PubMed: Rapid Detection of Small Molecule Metabolites in Serum of Hepatocellular Carcinoma Patients Using Ultrafast Liquid Chromatography-Ion Trap-Time of Flight Tandem Mass Spectrometry. PubMed: Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia. PubMed: Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs. PubMed: Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. PubMed: Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis. PubMed: Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues. PubMed: The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. PubMed: A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry. PubMed: Long-chain N-vanillyl-acylamides from Capsicum oleoresin. PubMed: Synthesis and bioevaluation of omega-N-amino analogs of B13. PubMed: Inhibition of skin inflammation and atopic dermatitis by topical application of a novel ceramide derivative, K112PC-5, in mice. PubMed: Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids. PubMed: Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents. PubMed: Secondary metabolites from endophytic Streptomyces sp. Lz531. PubMed: Identification of fatty acids and fatty acid amides in human meibomian gland secretions. PubMed: Differential involvement of ceramide in TNFalpha-mediated activation of NF-kappaB in primary human keratinocytes and HaCaT keratinocytes. PubMed: The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. PubMed: Supercritical CO2 as a reaction medium for synthesis of capsaicin analogues by lipase-catalyzed transacylation of capsaicin. PubMed: Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. PubMed: Reversible photochemistry in a chlorophyll model system. PubMed: Endotoxic activity of complexes of myristic acid and proteins. PubMed: Omega-1, Omega-2 and Omega-3 hydroxylation of long-chain fatty acids, amides and alcohols by a soluble enzyme system from Bacillus megaterium.